Benzinga's Top Initiations
Analysts at Citigroup initiated coverage on shares of The Bank Of Nova Scotia (NYSE: BNS) with a “neutral” rating. Bank Of Nova Scotia's shares closed at $55.91 yesterday. Bank Of Nova Scotia's trailing-twelve-month operating margin is 43.36%.
Roth Capital initiated coverage on shares of Alexza Pharmaceuticals (NASDAQ: ALXA) with a “buy” rating. Alexza Pharmaceuticals' shares closed at $5.47 yesterday. Alexza Pharmaceuticals had $25.51 million in total cash for the latest quarter.
FBR Capital initiated coverage on shares of NCI Building Systems (NYSE: NCS) with an “outperform” rating. NCI Building Systems' stock closed at $12.98 yesterday. NCI Building Systems' trailing-twelve-month ROE is 0.86%.
Analysts at Barrington initiated coverage on shares of Medivation (NASDAQ: MDVN) with an “overweight” rating. Medivation's shares closed at $53.58 yesterday. Medivation's trailing-twelve-month revenue is $159.48 million.
Latest Ratings for BNS
|Nov 2016||Credit Suisse||Assumes||Neutral|
|Nov 2016||Bank of America||Initiates Coverage On||Buy|
|Sep 2016||Dundee||Initiates Coverage on||Buy|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.